CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
Ambroxol hydrochloride soft pastille +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02572609
NCT02572609Phase 1Completed
CompareCT.gov

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

Boehringer Ingelheim·interventional·Posted Oct 9, 2015·Updated Dec 31, 2015

In Brief

A Phase 1 clinical trial evaluating Ambroxol hydrochloride soft pastille and Mucosolvan ® adult syrup for Healthy. Completed.

Detailed Summary

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH \& Co. KG to Boehringer Ingelheim compared to ambroxol hydrochloride syrup (Mucosolvan® adult syrup), manufactured by Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 9, 2015
Enrollment StartNov 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.7 years ago

Interventions

Ambroxol hydrochloride soft pastilledrug

Mucosolvan ® adult syrupdrug